Qube Research & Technologies »

Immunome shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Immunome (IMNM) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Immunome

Tip: Access up to 7 years of quarterly data

All positions including Immunome held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunome by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2023-09-30 $84 10 8.40

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Apple Call Option (AAPL)
Microsoft Corporation Call Option (MSFT)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Amazon Call Option (AMZN)
Visa Com Cl A Call Option (V)
Meta Platforms Cl A Call Option (META)
Adobe Systems Incorporated Call Option (ADBE)
McDonald's Corporation Call Option (MCD)
NVIDIA Corporation Call Option (NVDA)
salesforce Call Option (CRM)
Netflix Call Option (NFLX)
Johnson & Johnson Put Option (JNJ)
Cisco Systems Put Option (CSCO)
Bank of America Corporation Call Option (BAC)

View all positions for Qube Research & Technologies

Top funds holding Immunome

EcoR1 Capital
Redmile Group
Vanguard Group
Henderson Group
Avidity Partners Management
T. Rowe Price Associates
Point72 Asset Management
Brown Advisory Holdings Incorporated
Alpine Partners VI
TD Asset Management
Prentice Capital Management
Jane Street
Laurion Capital Management
Barclays
HPM Partners

View all funds holding Immunome